Mednet Logo
CommunityCardiology

How do you counsel patients with metabolic syndrome who decline statin therapy and have low coronary calcium scores regarding their long-term CVD risk?

Community PollStarted

How do you counsel patients with metabolic syndrome who decline statin therapy and have low coronary calcium scores regarding their long term CVD risk?

130 physicians have voted

Join Mednetto vote and see how they answered.

3 Answers
Mednet Member
Mednet MemberInvited Expert
Endocrinology · Duke Endocrinology Clinic
Answered on · Updated on

This is a great question with many ramifications, and I can only give an incomplete answer that includes personal opinion. First, what is the risk? The MESA Risk Score Calculator (check it out) gives a CAC percentile score as well as a 10-year risk. The 10-year risk may be low, but a high percentile...

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Endocrinology · University of Washington
Answered on · Updated on

Metabolic syndrome is associated with increased CV risk. The discussion regarding statin therapy for an individual will depend upon their age, family history of ASCVD, esp premature, and other risk factors like HTN, prediabetes. If the CAC score is zero, and there is statin hesitancy, one can defer ...

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Endocrinology · Newyork Presbyterian Columbia University Irving Medical Center
Answered on

Instead of using the term metabolic syndrome, I discuss the individual components each patient has and point to the risk of each; each should be treated if not already optimized. I make the point that in view of the other risks, an LDL below 100 (or lower, depending on CAC) will result in short-term...

Join for free or sign in to see the full answer